This is a plain-English translation of the academic paper above, prepared for patients, referring clinicians, and other non-specialist readers. It preserves the structure of the original paper while removing technical jargon. For the full clinical paper, follow the PubMed or DOI links.
What is this paper
An international consensus statement, contributed to by Professor Heidari among many specialists, on how to recognise and manage rare but serious fungal and atypical (non-bacterial) infections that can colonise an artificial hip or knee joint.
Why does it matter
Most infections around joint replacements are caused by bacteria, and the standard treatments (antibiotics and revision surgery) are well rehearsed. Fungal and atypical pathogens are rarer, harder to diagnose, and often require longer or different treatment with antifungal medication. Consensus statements pull together expert opinion to give surgeons a starting framework where high-quality randomised evidence does not yet exist. This document is a consensus paper rather than an original research study, and PubMed does not provide a structured abstract; the full text is available through the journal.
Source: Gebauer M, Frommelt L, Achan P, Board TN, Conway J, Griffin W, et al. (Heidari N). Management of fungal or atypical periprosthetic joint infections. Journal of Orthopaedic Research 2014;32 Suppl 1:S147-51. doi:10.1002/jor.22559
Read full open-access paper (PDF) → Read original on PubMed → ← Back to research library